Search

everythinglearnresearchcommunity

for

Search:↓

Hair/scalp cloning for unlimited transplants is likely a decade away, with prior transplants not significantly affecting future options. Advances in AI and research in wound-induced hair neogenesis are promising, but infrastructure and technology constraints remain challenges.

A person had a hair transplant using FUE with 4150 grafts after a previous FUT with 2000 grafts and is now using Dutasteride and oral Minoxidil. They are concerned about hair gaps on the side, questioning if they are a result of the transplant and if they are temporary.

Hair loss has slowed or stopped after 5 months of daily oral minoxidil and finasteride treatment, with ketoconazole shampoo used twice a week. Noticeable thickening is observed, especially on the mid scalp.

A 24-year-old with early hair loss is managing it with finasteride, minoxidil, and dutasteride, and is considering using a hair system for more styling options while maintaining transparency. They emphasize confidence and self-expression over hair, viewing it as an amplifier rather than a foundation.

Hair growth caps and helmets using low-level laser therapy (LLLT) show potential for treating androgenetic alopecia, but more research is needed. Users often combine these devices with treatments like minoxidil and finasteride for better results.

Hair loss can be caused by various factors such as stress, thyroid issues, and genetics. Treatments mentioned include dutasteride, DHT blockers, and thyroid medication, though results vary.

Finasteride and Dutasteride do not cause depression or mood disorders; hair loss itself may be a more significant factor. Some users experience side effects from Finasteride, but it is generally well-tolerated.

Lowering DHT can improve skin quality and reduce scalp issues. Finasteride is effective for hair regrowth and improving skin texture, while dutasteride may increase oiliness and shedding for some users.

Hair loss requires proper diagnosis as it can have various causes, and treatments like finasteride, minoxidil, and dutasteride are often used. Many people express frustration with dermatologists and turn to self-research and alternative sources for treatment.

The user is using minoxidil, topical finasteride, Nizoral shampoo, and a dermaroller for hair regrowth but is experiencing changes in sexual function. They are concerned about whether these changes are due to the treatment and are seeking advice on continuing hair growth without affecting sexuality.

Hair loss treatments like Dutasteride, RU58841, Finasteride, and Minoxidil are discussed, with skepticism about their effectiveness without photographic evidence. The conversation humorously critiques the reliance on anecdotal evidence for these treatments.

Hair regrowth using finasteride 1mg daily and topical minoxidil twice daily, with a hair transplant after three years, showed significant improvement over four years. The user is satisfied with the results despite not having access to oral minoxidil.

Hair loss is linked to a higher rate of body dysmorphic disorder (BDD), OCD, and depression. Finasteride and dutasteride are not linked to increased suicidal risk, though some users report mental health side effects.

Hair growth relies on mechanical forces, not just chemicals, with tissue acting like a motor. Minoxidil and finasteride help, but maintaining tissue elasticity and addressing mechanical issues are essential.

The conversation discusses hair loss treatments, including the use of minoxidil, finasteride, dutasteride, RU58841, and Nizoral. Participants emphasize the importance of finasteride and minoxidil, while also considering factors like diet, stress, and scalp health.

Hair loss affects mental health and self-esteem, causing anxiety and depression. Treatments like finasteride, minoxidil, and hair transplants help some, but others continue to struggle.

Hair loss was triggered by a testosterone and Masteron cycle, causing scalp tension and shedding. Topical finasteride, RU58841, and oral minoxidil were used to stop shedding and improve scalp condition.

A user successfully regrew hair using 1mg finasteride, switching to 0.5mg dutasteride, and maintaining 5mg oral minoxidil, with significant improvements noted after switching to dutasteride. The user experienced shedding phases but ultimately achieved regrowth and is now comfortable without wearing a hat.

Rapid weight loss may have triggered increased hair shedding. Continuing with finasteride, microneedling, a healthy diet, and supplements like MSM and vitamin B is advised, but results may take 6-12 months.

The user shared hair regrowth results after 6 months using finasteride, minoxidil, ketoconazole shampoo, and dermastamp, considering adding dutasteride or a hair transplant. They previously had a hair transplant and did not take medications initially, leading to further hair loss.

Hair loss is often linked to inflammation and DHT, with treatments like finasteride, dutasteride, and minoxidil being effective for many. Natural remedies like turmeric and oils are discussed, but medications are generally seen as more reliable for managing genetic hair loss.

The user experienced significant hair shedding after using a dermapen at 1.5mm weekly, which they later realized was too much. They are now using a dermapen at 0.75mm weekly and are also using topical minoxidil twice daily and finasteride 1.25mg daily.

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

Topical roflumilast is effective for reducing inflammation in various scalp conditions like seborrheic dermatitis, psoriasis, and eczema, but not proven to stop scarring alopecia. Alternatives like apremilast and Vtama are also discussed for their anti-inflammatory benefits.

The conversation is about a hair loss treatment plan involving finasteride, minoxidil, microneedling, GHK-CU injections, Nizoral shampoo, and RU58841. The user is advised to start with a simpler regimen to minimize side effects and assess effectiveness before adding more treatments.

A 33-year-old experienced significant hair loss after a depressive episode and taking paroxetine, possibly due to telogen effluvium or androgenic alopecia. Suggestions included reducing alcohol, considering finasteride and minoxidil, and consulting a doctor about antidepressant side effects.

An 18-year-old with early hair loss is advised to consider minoxidil and finasteride, with a doctor's consultation recommended. Alternatives like a hair system or shaving are suggested due to potential medication side effects and lifelong commitment.

The user shared their hair loss journey, using Minoxidil 2%, Serenoa repens, topical finasteride, a topical antiandrogen, Vitamin D, and lifestyle changes, noting improvements but still seeking more density. They are considering switching to Minoxidil 5% but prefer focusing on finasteride and antiandrogen for better results.

After stopping finasteride, the user retained hair without noticeable balding, suggesting an unusual reaction to the medication. The user initially experienced rapid hair loss and itchiness, possibly due to male pattern baldness, but maintained hair stability after tapering off finasteride.

Hair follicle stem cells remain in bald individuals, but progenitor cells do not, raising questions about hair regrowth claims by Pelage. PP405 is discussed as a potential treatment, with skepticism about its effectiveness compared to existing treatments like Minoxidil and Finasteride.